STOCK TITAN

[Form 4] Anterix Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 filing summary – Anterix Inc. (ATEX): On 08/05/2025, director and 10 % owner Jeffrey A. Altman accepted 7,767 restricted shares of ATEX common stock as non-employee director compensation (code “A”) at a $0 acquisition cost. The award vests on the earlier of 05 Aug 2026 or the next annual shareholder meeting, subject to insider-trading blackout rules.

Following the grant, Altman’s direct holdings rise to 15,416 shares. He also reports 124,492 additional directly held shares and 5,411,776 shares held indirectly via Owl Creek funds, leaving the Owl Creek/Altman group comfortably above the 10 % ownership threshold. No sales, option exercises, or derivative trades were reported, so overall economic exposure remains largely unchanged. The transaction is routine, modest in size relative to Altman’s existing 5.55 million-share exposure, and has limited impact on Anterix’s ownership structure or float.

Riepilogo deposito Modulo 4 – Anterix Inc. (ATEX): Il 08/05/2025, il direttore e azionista al 10% Jeffrey A. Altman ha accettato 7.767 azioni ristrette di azioni ordinarie ATEX come compenso per direttore non dipendente (codice “A”) a costo di acquisizione pari a $0. Il premio si consolida alla data precedente tra il 05 agosto 2026 o la prossima assemblea annuale degli azionisti, soggetto alle norme sul blackout per insider trading.

Successivamente alla concessione, le posizioni dirette di Altman salgono a 15.416 azioni. Riporta inoltre 124.492 azioni detenute direttamente e 5.411.776 azioni detenute indirettamente tramite i fondi Owl Creek, mantenendo il gruppo Owl Creek/Altman ben oltre la soglia di proprietà del 10%. Non sono state segnalate vendite, esercizi di opzioni o operazioni su derivati, pertanto l’esposizione economica complessiva rimane sostanzialmente invariata. L’operazione è di routine, di dimensioni modeste rispetto all’esposizione di 5,55 milioni di azioni già detenuta da Altman, e ha un impatto limitato sulla struttura proprietaria o sul flottante di Anterix.

Resumen de presentación del Formulario 4 – Anterix Inc. (ATEX): El 08/05/2025, el director y propietario del 10% Jeffrey A. Altman aceptó 7,767 acciones restringidas de acciones comunes de ATEX como compensación por director no empleado (código “A”) sin costo de adquisición. La concesión se consolida en la fecha anterior entre el 05 de agosto de 2026 o la próxima junta anual de accionistas, sujeta a las reglas de bloqueo por operaciones con información privilegiada.

Tras la concesión, las participaciones directas de Altman aumentan a 15,416 acciones. También reporta 124,492 acciones adicionales en propiedad directa y 5,411,776 acciones en propiedad indirecta a través de los fondos Owl Creek, manteniendo al grupo Owl Creek/Altman cómodamente por encima del umbral del 10% de propiedad. No se reportaron ventas, ejercicios de opciones ni operaciones con derivados, por lo que la exposición económica general permanece prácticamente sin cambios. La transacción es rutinaria, modesta en tamaño en relación con la exposición existente de 5.55 millones de acciones de Altman, y tiene un impacto limitado en la estructura de propiedad o el flotante de Anterix.

폼 4 제출 요약 – Anterix Inc. (ATEX): 2025년 8월 5일, 이사이자 10% 주주인 Jeffrey A. Altman은 비임원 이사 보상으로 7,767주의 제한 주식을 $0 취득 비용으로 수락했습니다(코드 “A”). 이 보상은 2026년 8월 5일 또는 다음 연례 주주총회 중 먼저 도래하는 시점에 베스팅되며, 내부자 거래 금지 규정의 적용을 받습니다.

수여 후 Altman의 직접 보유 주식은 15,416주로 증가했습니다. 또한 124,492주의 추가 직접 보유 주식Owl Creek 펀드를 통한 5,411,776주의 간접 보유 주식을 보고하여 Owl Creek/Altman 그룹이 10% 소유권 기준을 여유롭게 초과하고 있습니다. 매도, 옵션 행사 또는 파생상품 거래는 보고되지 않아 전체 경제적 노출은 거의 변동이 없습니다. 이번 거래는 일상적이며 Altman의 기존 555만 주 노출에 비해 규모가 작고, Anterix의 소유 구조나 유통 주식에 미치는 영향도 제한적입니다.

Résumé du dépôt du formulaire 4 – Anterix Inc. (ATEX) : Le 08/05/2025, le directeur et détenteur de 10 % Jeffrey A. Altman a accepté 7 767 actions restreintes d’actions ordinaires ATEX en tant que rémunération de directeur non salarié (code « A ») à un coût d’acquisition de 0 $. La récompense est acquise à la première date entre le 5 août 2026 ou la prochaine assemblée annuelle des actionnaires, sous réserve des règles de blocage liées aux opérations d’initiés.

Suite à cette attribution, les participations directes d’Altman augmentent à 15 416 actions. Il déclare également 124 492 actions supplémentaires détenues directement et 5 411 776 actions détenues indirectement via les fonds Owl Creek, maintenant ainsi le groupe Owl Creek/Altman bien au-dessus du seuil de détention de 10 %. Aucune vente, exercice d’options ou transaction dérivée n’a été signalée, de sorte que l’exposition économique globale reste largement inchangée. La transaction est de routine, modeste en taille par rapport à l’exposition existante de 5,55 millions d’actions d’Altman, et a un impact limité sur la structure de propriété ou le flottant d’Anterix.

Formular 4 Einreichungsübersicht – Anterix Inc. (ATEX): Am 05.08.2025 akzeptierte der Direktor und 10%-Eigentümer Jeffrey A. Altman 7.767 eingeschränkte Aktien der ATEX-Stammaktien als Vergütung für nicht angestellte Direktoren (Code „A“) zu einem Erwerbspreis von 0 $. Die Zuteilung wird zum früheren Zeitpunkt des 05. August 2026 oder der nächsten jährlichen Hauptversammlung fällig, vorbehaltlich der Insider-Handelssperrregeln.

Nach der Zuteilung steigen Altmans direkte Beteiligungen auf 15.416 Aktien. Er meldet außerdem 124.492 weitere direkt gehaltene Aktien und 5.411.776 Aktien, die indirekt über Owl Creek Fonds gehalten werden, womit die Owl Creek/Altman-Gruppe deutlich über der 10 %-Besitzschwelle liegt. Es wurden keine Verkäufe, Optionsausübungen oder Derivategeschäfte gemeldet, sodass die wirtschaftliche Gesamtposition weitgehend unverändert bleibt. Die Transaktion ist routinemäßig, im Vergleich zu Altmans bestehender 5,55-Millionen-Aktien-Position moderat und hat nur begrenzte Auswirkungen auf die Eigentümerstruktur oder den Streubesitz von Anterix.

Positive
  • Director/10 % owner acquired 7,767 additional shares, modestly increasing direct alignment with shareholders.
  • No insider sales reported, maintaining confidence signal and stable ownership.
Negative
  • None.

Insights

TL;DR 7,767-share grant modestly lifts insider’s direct stake; no shares sold, overall exposure unchanged.

The filing shows Altman continuing to accumulate equity through routine board compensation rather than open-market purchasing. The 7.8 k-share grant is immaterial relative to his 5.4 m indirect holdings and Anterix’s 19 m share float, so market impact should be negligible. Still, the absence of sales and maintenance of a >10 % position reinforce long-term alignment between the director and shareholders.

TL;DR Standard director compensation; confirms insider retains sizable 10 %+ stake.

The award follows customary vesting terms and complies with Rule 10b5-1 safeguards. No indication of intent to dispose. Continued disclosure of indirect shares via Owl Creek funds is important for transparency, but there are no red-flags or governance concerns. Impact on voting control and free float is effectively nil.

Riepilogo deposito Modulo 4 – Anterix Inc. (ATEX): Il 08/05/2025, il direttore e azionista al 10% Jeffrey A. Altman ha accettato 7.767 azioni ristrette di azioni ordinarie ATEX come compenso per direttore non dipendente (codice “A”) a costo di acquisizione pari a $0. Il premio si consolida alla data precedente tra il 05 agosto 2026 o la prossima assemblea annuale degli azionisti, soggetto alle norme sul blackout per insider trading.

Successivamente alla concessione, le posizioni dirette di Altman salgono a 15.416 azioni. Riporta inoltre 124.492 azioni detenute direttamente e 5.411.776 azioni detenute indirettamente tramite i fondi Owl Creek, mantenendo il gruppo Owl Creek/Altman ben oltre la soglia di proprietà del 10%. Non sono state segnalate vendite, esercizi di opzioni o operazioni su derivati, pertanto l’esposizione economica complessiva rimane sostanzialmente invariata. L’operazione è di routine, di dimensioni modeste rispetto all’esposizione di 5,55 milioni di azioni già detenuta da Altman, e ha un impatto limitato sulla struttura proprietaria o sul flottante di Anterix.

Resumen de presentación del Formulario 4 – Anterix Inc. (ATEX): El 08/05/2025, el director y propietario del 10% Jeffrey A. Altman aceptó 7,767 acciones restringidas de acciones comunes de ATEX como compensación por director no empleado (código “A”) sin costo de adquisición. La concesión se consolida en la fecha anterior entre el 05 de agosto de 2026 o la próxima junta anual de accionistas, sujeta a las reglas de bloqueo por operaciones con información privilegiada.

Tras la concesión, las participaciones directas de Altman aumentan a 15,416 acciones. También reporta 124,492 acciones adicionales en propiedad directa y 5,411,776 acciones en propiedad indirecta a través de los fondos Owl Creek, manteniendo al grupo Owl Creek/Altman cómodamente por encima del umbral del 10% de propiedad. No se reportaron ventas, ejercicios de opciones ni operaciones con derivados, por lo que la exposición económica general permanece prácticamente sin cambios. La transacción es rutinaria, modesta en tamaño en relación con la exposición existente de 5.55 millones de acciones de Altman, y tiene un impacto limitado en la estructura de propiedad o el flotante de Anterix.

폼 4 제출 요약 – Anterix Inc. (ATEX): 2025년 8월 5일, 이사이자 10% 주주인 Jeffrey A. Altman은 비임원 이사 보상으로 7,767주의 제한 주식을 $0 취득 비용으로 수락했습니다(코드 “A”). 이 보상은 2026년 8월 5일 또는 다음 연례 주주총회 중 먼저 도래하는 시점에 베스팅되며, 내부자 거래 금지 규정의 적용을 받습니다.

수여 후 Altman의 직접 보유 주식은 15,416주로 증가했습니다. 또한 124,492주의 추가 직접 보유 주식Owl Creek 펀드를 통한 5,411,776주의 간접 보유 주식을 보고하여 Owl Creek/Altman 그룹이 10% 소유권 기준을 여유롭게 초과하고 있습니다. 매도, 옵션 행사 또는 파생상품 거래는 보고되지 않아 전체 경제적 노출은 거의 변동이 없습니다. 이번 거래는 일상적이며 Altman의 기존 555만 주 노출에 비해 규모가 작고, Anterix의 소유 구조나 유통 주식에 미치는 영향도 제한적입니다.

Résumé du dépôt du formulaire 4 – Anterix Inc. (ATEX) : Le 08/05/2025, le directeur et détenteur de 10 % Jeffrey A. Altman a accepté 7 767 actions restreintes d’actions ordinaires ATEX en tant que rémunération de directeur non salarié (code « A ») à un coût d’acquisition de 0 $. La récompense est acquise à la première date entre le 5 août 2026 ou la prochaine assemblée annuelle des actionnaires, sous réserve des règles de blocage liées aux opérations d’initiés.

Suite à cette attribution, les participations directes d’Altman augmentent à 15 416 actions. Il déclare également 124 492 actions supplémentaires détenues directement et 5 411 776 actions détenues indirectement via les fonds Owl Creek, maintenant ainsi le groupe Owl Creek/Altman bien au-dessus du seuil de détention de 10 %. Aucune vente, exercice d’options ou transaction dérivée n’a été signalée, de sorte que l’exposition économique globale reste largement inchangée. La transaction est de routine, modeste en taille par rapport à l’exposition existante de 5,55 millions d’actions d’Altman, et a un impact limité sur la structure de propriété ou le flottant d’Anterix.

Formular 4 Einreichungsübersicht – Anterix Inc. (ATEX): Am 05.08.2025 akzeptierte der Direktor und 10%-Eigentümer Jeffrey A. Altman 7.767 eingeschränkte Aktien der ATEX-Stammaktien als Vergütung für nicht angestellte Direktoren (Code „A“) zu einem Erwerbspreis von 0 $. Die Zuteilung wird zum früheren Zeitpunkt des 05. August 2026 oder der nächsten jährlichen Hauptversammlung fällig, vorbehaltlich der Insider-Handelssperrregeln.

Nach der Zuteilung steigen Altmans direkte Beteiligungen auf 15.416 Aktien. Er meldet außerdem 124.492 weitere direkt gehaltene Aktien und 5.411.776 Aktien, die indirekt über Owl Creek Fonds gehalten werden, womit die Owl Creek/Altman-Gruppe deutlich über der 10 %-Besitzschwelle liegt. Es wurden keine Verkäufe, Optionsausübungen oder Derivategeschäfte gemeldet, sodass die wirtschaftliche Gesamtposition weitgehend unverändert bleibt. Die Transaktion ist routinemäßig, im Vergleich zu Altmans bestehender 5,55-Millionen-Aktien-Position moderat und hat nur begrenzte Auswirkungen auf die Eigentümerstruktur oder den Streubesitz von Anterix.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ALTMAN JEFFREY A

(Last) (First) (Middle)
C/O OWL CREEK ASSET MANAGEMENT, L.P.
640 FIFTH AVENUE, 20TH FLOOR

(Street)
NEW YORK NY 10019

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.0001 per share ("Common Stock") 08/05/2025 A 7,767(1) A $0 15,416 D(2)(5)
Common Stock 124,492 D(3)(5)
Common Stock 5,411,776 I See footnotes(4)(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
ALTMAN JEFFREY A

(Last) (First) (Middle)
C/O OWL CREEK ASSET MANAGEMENT, L.P.
640 FIFTH AVENUE, 20TH FLOOR

(Street)
NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Owl Creek Asset Management, L.P.

(Last) (First) (Middle)
640 FIFTH AVENUE
20TH FLOOR

(Street)
NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. The restricted stock vests in full on the earlier of (i) August 5, 2026 or (ii) the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of Common Stock by the Reporting Person (as defined below) in the open market would be permitted under the Issuer's Insider Trading Policy.
2. Represents securities granted to Jeffrey Altman ("Mr. Altman" or the "Reporting Person") as compensation for his services as a non-employee director on the Issuer's board of directors. Mr. Altman may be deemed to hold the securities reported herein for the benefit of certain funds (the "Owl Creek Funds") to which Owl Creek Asset Management, L.P., a Delaware limited partnership (the "Investment Manager"), serves as investment manager.
3. Represents shares of Common Stock directly held by Mr. Altman.
4. These securities are held by the Owl Creek Funds. Mr. Altman is the managing member of the general partner of the Investment Manager.
5. Each of the Investment Manager and Mr. Altman disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.
/s/ Jeffrey A. Altman 08/07/2025
Owl Creek Asset Management, L.P. Owl Creek Asset Management, L.P. By: /s/ Jeffrey A. Altman, Managing Member 08/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ATEX shares did Jeffrey Altman acquire on 08/05/2025?

He received 7,767 restricted shares as board compensation.

What is Jeffrey Altman’s total direct ownership in Anterix after the grant?

His direct holdings stand at 15,416 common shares.

How many ATEX shares are held indirectly by Owl Creek funds?

The Form 4 lists 5,411,776 shares held indirectly through Owl Creek funds.

When will the newly granted restricted shares vest?

They vest on the earlier of 05 Aug 2026 or the next annual shareholder meeting.

Were any ATEX shares sold or derivatives exercised in this filing?

No; the filing shows only an acquisition, with zero sales or derivative transactions.
Anterix Inc

NASDAQ:ATEX

ATEX Rankings

ATEX Latest News

ATEX Latest SEC Filings

ATEX Stock Data

408.50M
18.32M
1.78%
89.43%
5.34%
Telecom Services
Telephone Communications (no Radiotelephone)
Link
United States
WOODLAND PARK